ConductScience.org, home

Trial · NCT05228418

Bridging ED to Outpatient AUD Therapy With Naltrexone

NCT05228418, Phase 4, Unknown, Albert Einstein Healthcare Network

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Bridging ED to Outpatient AUD Therapy With Naltrexone. Trials, record NCT05228418. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05228418

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Bridging ED to Outpatient AUD Therapy With Naltrexone
NCT number
NCT05228418
Status
Unknown
Phases
Phase 4
Enrollment
20 participants, estimated
Lead sponsor
Albert Einstein Healthcare Network
Conditions
Alcohol Use Disorder
Interventions
Naltrexone Pill
First posted
2022-02-08
Last updated
2022-02-08

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySuccessful referral and follow-up in MAT clinic4 weeks
The primary endpoint is percentage of patients who are successfully referred to outpatient MAT treatment in our hospital's outpatient clinic and percentage of people who stay in treatment at the intake and subsequent follow-up outpatient clinic visit. (i.e. % of patients who remain in treatment at the initial outpatient intake visit scheduled within 1 week of the initial index ED visit and the follow-up appointment 4 weeks after the intake visit)
SecondaryAlcohol use severity measures4 weeks
We will track variables that we believe to correlate with alcohol use disorder, such as estimation of weekly alcohol intake, alcohol cravings cravings, ED visits for alcohol use for the previous week via surveys administered during the intake outpatient MAT visit and the follow-up appointment 4 weeks later.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
15811981BACKGROUNDPubMed
21761949BACKGROUNDPubMed
34353648BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05228418

GET https://conductscience.org/api/trials/v1/NCT05228418/registered